Back to Intelligence
#us-healthcare
(2 articles)Risk & Disruption
CriticalMay 6, 2026US Drug Supply Exposed: Critical China Dependency Risk
The US pharmaceutical supply chain faces a critical structural vulnerability stemming from significant dependency on China for active pharmaceutical ingredients (APIs) and drug manufacturing. This con
Washington Examiner#pharmaceutical-supply-chain#china-dependency#drug-manufacturing
Risk & Disruption
High ImpactApr 21, 2026100 Essential US Medicines Face Hidden Supply-Chain Risks
A comprehensive analysis from CIDRAP identifies significant hidden vulnerabilities within the US pharmaceutical supply chain that threaten the availability of approximately 100 essential medicines. Th
Google News - Supply Chain#pharmaceutical-supply-chain#medicine-shortages#supply-chain-risk